The Gates Foundation announced its largest budget to date and committed to increased funding in the next two years.
 
Published on MedED:  15 January 2024
Type of article: News
MedED Catalogue Reference: MNG0013

Category: News | Public Health 
Category Cross-reference: Public Health | Paediatrics | Infectious Diseases

Keywords: Africa, vaccines, public health, healthcare funding

Top




15 January 2024, 14:00
Contributor: Linda Ravenhill

 

Davos, Switzerland, 15 January 2024
 

The Bill & Malinda Gates Foundation announced that it has approved its largest-ever budget. $8.6 billion has been allocated to healthcare initiatives in 2024, and the organisation has committed to increasing its annual spend to $9 billion by 2026.
 

The budget, which represents a 4% increase over the 2023 allocation, contrasts starkly with the decline in overall global healthcare contributions. Sub-Saharan Africa has been particularly hard-hit, with global funding in the region declining by nearly 8% in 2022. 


In a press statement released by the Foundation today, Bill Gates, the co-chair of the Gates Foundation, commented: 

"We can't talk about the future of humanity without talking about the future of health. Every day, newborn babies and young children die simply because of where they were born. Mothers die giving birth, leaving families devastated. That keeps me up at night. It's unacceptable, particularly because we have already developed many of the solutions that could save their lives. Building a stronger, more stable world starts with good health."


The additional resources allocated for 2024, which include financial and human capital, aim to expedite initiatives that offer the most substantial impact across diverse priorities of the Foundation. These include eradicating polio, expanding child azithromycin distribution in high-mortality areas, enhancing postsecondary education's digital courseware, and advancing the global TB drug portfolio.


Several of the health innovations funded by the Foundation will be presented at the Foundation's "The Future of Health" event at the World Economic Forum Annual Meeting. These include:
 

A package of tools that aims to save 65,000 women by 2030 by reducing and preventing postpartum haemorrhage (PPH), the leading global cause of maternal death. In trials, these tools and interventions reduced severe bleeding cases by 60%.

A single-dose HPV vaccine to combat one of the most prevalent cancers in women globally. The one-dose vaccine, which will be especially beneficial in overcoming vaccination barriers, maintains high and lasting efficacy. It is estimated that 110 million cases of cervical cancer could potentially be prevented through its use.

An AI-powered ultrasound which can identify at-risk pregnancies could save 390,000 infant lives by 2030. This innovation aids health workers and would be particularly beneficial in low-resource settings.

Microneedle array patches offer a needle-free, accessible way to administer vaccines through the skin, eliminating the need for traditional needles and complex storage solutions. Initial trials indicate that the patches deliver the measles-rubella vaccines as safely and effectively as needle-based delivery and generate a comparable immune response.

Cost-effective test strips that could cut production and shipping expenses, enabling mass production and swift response during outbreaks. Their affordability and scalability could enhance testing availability, aiding in public health emergencies.

Micronutrient supplements that replenish a pregnant woman's nutrients could reduce low birth weight and preterm birth risks. Available now, these supplements have shown enhanced efficacy among anaemic and underweight women and could prevent 425,000 stillbirths.
 

Mark Suzman, Gates Foundation CEO, had this to say:

"The Gates Foundation measures impact in terms of lives saved and opportunities provided to the poorest. This new high-water mark for our budget will further our mission to help create a world where everyone has the opportunity to live a healthy, productive life."
 

 


Back to top 

 


Disclaimer
This article is compiled from various  resources researched and compiled by the contributor. It is in no way presented as an original work.  Every effort has been made to correctly attribute quotes and content. Where possible,  all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us 


Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.
 
 
 
 
Rapid SSL

The Medical Education Network
Powered by eLecture, a VisualLive Solution